The executive team at Imalac has a strong history in both the biotech industry and in investments. With experience as a limited partner at NGT3 Biotech Incubator Nazareth Israel, a consultant at DermTech international, and the Vice-President of Portfolio Development at Jacobs Investment, LLC, the team is well-equipped to handle the company's finances. Additionally, the team's experience with NGT-VC at Galilee Tech Ventures gives them the perfect background to understand and invest in the company's technology. Finally, the team's education histories provide a strong foundation in chemistry and other sciences, ensuring that they are able to make informed decisions about the company's products.
View all